Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Which Dividend Aristocrats Etf Has Strongest Growth compares funds on growth metrics, valuation trends, and payout stability for informed choice.
28,113 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Bitcoin, Ethereum, and XRP led a weekend comeback, lifting the total crypto market cap and centering attention on a p...
U.S. regulators propose bank-style rules for stablecoin issuers, demanding AML programs, data reporting, and reserve ...
As earnings season kicks off, public comments surge over the SEC's bid to allow semiannual reporting. ExxonMobil's CF...
Universal Corp misses EPS and swings to a loss in the third quarter, triggering a double-digit stock drop. Analysts f...
SanDisk announced a $1 billion strategic equity investment in Nanya Technology, prompting a roughly 6% share decline ...
Rent prices dropping nationwide are reshaping tenant leverage as supply catches up with demand. This report flags whe...
Investors brace for MSCI’s late-June decision on Indonesia’s market status, with potential outflows tied to a downgra...
A retiree’s hesitation to touch a Roth IRA for fear of higher Medicare costs and Social Security taxes is untrue: qua...
The FAA has halted all JetBlue flights at the airline’s request, triggering widespread travel disruption and a swift ...
Brokerages launch pilots that allow 13-year-olds to trade stocks with limited parental approval, prompting wide-rangi...
Dogecoin has fallen under the 10-cent threshold amid a broad risk-off in crypto markets. With no single catalyst, tra...